Skip to main content
. 2021 Mar 31;21:141. doi: 10.1186/s12876-021-01723-7

Table 2.

Detailed characteristics of the enrolled UC patients

UC Patient Age Gender Mayo endoscopic subscore Medication Activity Duration of remission
1 55 F 5 5-ASA Mild
2 51 M 3 5-ASA Mild
3 50 M 6 Unknown Moderate
4 48 M 6 Unknown Moderate
5 60 F 0 5-ASA Remission 1 year
6 41 F 0 AZA Remission Unknown
7 50 F 0 Unknown Remission 6 years
8 50 F 0 5-ASA Remission Unknown
9 35 F 1 5-ASA Remission 3 years
10 49 M 0 5-ASA Remission 1 year
11 53 F 0 5-ASA Remission Unknown
12 35 F 0 Unknown Remission 9 years
13 59 M 0 Unknown Remission 10 years
14 46 F 0 5-ASA Remission 3 year

F: female, M: male